vTv Therapeutics
VTVT
42 hedge funds and large institutions have $33.7M invested in vTv Therapeutics in 2015 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 4 closing their positions.
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
14% more funds holding
Funds holding: 37 → 42 (+5)
3% more capital invested
Capital invested by funds: $32.7M → $33.7M (+$1M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$506K |
| 2 |
State Street
Boston,
Massachusetts
|
+$388K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$311K |
| 4 |
Millennium Management
New York
|
+$272K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$154K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$849K |
| 2 |
PSC
Piper Sandler & Co
Minneapolis,
Minnesota
|
-$626K |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$226K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$202K |
| 5 |
UBS AM
Chicago,
Illinois
|
-$182K |
VTVT Hedge Fund Activity: Q4 2015 in Review
42 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q4 2015, worth a combined $33.7M — up 3.1% from $32.7M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new VTVT positions and 4 closed out — a net gain of 5 holders — while 13 added to existing stakes and 14 trimmed.
The largest buyer was Oxford Asset Management, opening a new position worth an estimated $506K. The largest seller was Morgan Stanley, cutting an estimated $849K.
- 42 institutional investors held vTv Therapeutics (VTVT) as of Q4 2015, up from 37 in Q3 2015.
- Funds reported $33.7M of vTv Therapeutics stock for Q4 2015, up 3.1% quarter-over-quarter.
- 9 funds opened new vTv Therapeutics positions in Q4 2015 and 4 closed out, a net change of +5 holders.
- The largest vTv Therapeutics buyer in Q4 2015 was Oxford Asset Management, an estimated $506K added.
- The largest vTv Therapeutics seller in Q4 2015 was Morgan Stanley, an estimated $849K sold.
Based on aggregated 13F filings for Q4 2015.